fludarabine,cyclophosphamide,allo-316,allo-647
allogene therapeutics
['traverse', 'thank you']
thank you, dr srour, for stopping by and discussing the phase 1 traverse trial with #onclive at #aacr23! check back to to hear more! 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.